SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-192617
Filing Date
2020-07-14
Accepted
2020-07-14 16:13:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS FILED PURSUANT TO RULE 424(B)(5) d934315d424b5.htm 424B5 110957
2 GRAPHIC g934315g09z27.jpg GRAPHIC 40766
3 GRAPHIC g934315g87j56.jpg GRAPHIC 37701
4 GRAPHIC g934315g92r03.jpg GRAPHIC 40802
  Complete submission text file 0001193125-20-192617.txt   264472
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239670 | Film No.: 201027292
SIC: 2834 Pharmaceutical Preparations